Tag: CSL

CSL profit, revenue up 10%, but share price falls

Posted on   |  by Peter Roberts
There seems to be no pleasing demanding shareholders with biotechnology giant CSL punished by the market despite announcing a greater than ten per cent rise in both revenues and...

Academy calls for manufacturing boost for vaccines

Posted on   |  by James Riley
Without the ability to produce vaccines onshore, Australia and the region remain vulnerable to supply shocks and ‘vaccine nationalism’, the Academy of Science says in a pre-budget submission to...

Vaccine maker CSL’s massive year, massive profits

Posted on   |  by Peter Roberts
Australia’s largest company by market capitalisation, biotechnology manufacturer CSL has powered ahead in the first half of the financial year reporting a net profit after tax up 44 per...

The Pivot: Lessons from the biotech frontline

Posted on   |  by Ian Nisbet
“If plan A doesn’t work, the alphabet has 25 more letters – 46 if you’re in Japan.” (Claire Cook, Seven Year Switch) In the late 1980s and early 1990s...

CSL to build $800m Melbourne vaccine facility

Posted on   |  by Peter Roberts
Biotechnology giant CSL will spend more than $800 million building a new vaccine manufacturing plant at the Melbourne Airport Business Park, with operations expected to start in 2026. The...

Govt seeks input on mass vaccine capability

Posted on   |  by James Riley
The federal government has put out a nationwide call to local manufacturers seeking information as part of preparation to produce future vaccines and treatments for COVID-19 at scale. The...
Newsletter Signup

Subscribe to our newsletter for InnovationAus news delivered right to your inbox.